Technical Specifications
| Drug Composition | Ibrutinib 140 mg Capsules |
|---|---|
| Variant / Strength | 140 mg |
| Dosage Form / Type | Capsules |
| Product Benefits | Mantle-cell lymphoma & Blood cancer (Chronic lymphocytic leukemia) |
| Packaging Type | Bottle |
| Delivery Time | 7 - 15 Days, as per delivery location. |
| Country of Origin | Made in India |
Product Overview & Description
Ibrutinib Capsule is prescribed for mantle-cell lymphoma and chronic lymphocytic leukemia, including cases that have undergone at least one prior therapy. The duration of treatment depends on your response, with the doctor conducting regular blood tests to monitor blood cell counts, as the medication can decrease cell numbers, potentially heightening susceptibility to infections. Common side effects include headache, diarrhea, and nausea.
Submit Quotation Request
Verified Customer Reviews (0)